217 related articles for article (PubMed ID: 22163258)
21. [Vaccinations in adults--who? when? why?].
Hofmann F
Internist (Berl); 2005 Feb; 46(2):206-13. PubMed ID: 15655680
[TBL] [Abstract][Full Text] [Related]
22. Vaccination Programs for Adults in Europe, 2019.
Cassimos DC; Effraimidou E; Medic S; Konstantinidis T; Theodoridou M; Maltezou HC
Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 31968652
[TBL] [Abstract][Full Text] [Related]
23. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
[TBL] [Abstract][Full Text] [Related]
24. [Determination of vaccination coverage and disease incidence using statutory health insurance data].
Reuss A; Feig M; Kappelmayer L; Eckmanns T; Poggensee G
Gesundheitswesen; 2010 Jun; 72(6):340-6. PubMed ID: 20446216
[TBL] [Abstract][Full Text] [Related]
25. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.
DeStefano F; Mullooly JP; Okoro CA; Chen RT; Marcy SM; Ward JI; Vadheim CM; Black SB; Shinefield HR; Davis RL; Bohlke K;
Pediatrics; 2001 Dec; 108(6):E112. PubMed ID: 11731639
[TBL] [Abstract][Full Text] [Related]
26. [Influenza, tetanus, and pertussis vaccination coverage among adults in Germany].
Bödeker B; Remschmidt C; Müters S; Wichmann O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):174-81. PubMed ID: 25446313
[TBL] [Abstract][Full Text] [Related]
27. Vaccination in Pregnancy.
Röbl-Mathieu M; Kunstein A; Liese J; Mertens T; Wojcinski M
Dtsch Arztebl Int; 2021 Apr; 118(15):262-268. PubMed ID: 34114547
[TBL] [Abstract][Full Text] [Related]
28. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
Dhillon S
BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
[TBL] [Abstract][Full Text] [Related]
29. [Vaccinations for pregnant women and women attempting to become pregnant].
Tempfer C
Gynakol Endokrinol; 2022; 20(2):93-100. PubMed ID: 35125986
[TBL] [Abstract][Full Text] [Related]
30. [Is complete immunity against measles a realistic target for patients with rheumatic diseases and how can it possibly be achieved?].
Braun J; Kiltz U; Müller-Ladner U
Z Rheumatol; 2020 Nov; 79(9):922-928. PubMed ID: 32945951
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
[TBL] [Abstract][Full Text] [Related]
32. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.
Hilgendorf I; Freund M; Jilg W; Einsele H; Gea-Banacloche J; Greinix H; Halter J; Lawitschka A; Wolff D; Meisel R
Vaccine; 2011 Apr; 29(16):2825-33. PubMed ID: 21345379
[TBL] [Abstract][Full Text] [Related]
33. [Responsibilities of the general practitioner in vaccination control].
Wahle K
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S65-70. PubMed ID: 19353474
[TBL] [Abstract][Full Text] [Related]
34. [Vaccination in Germany - Recommendations of STIKO].
Mertens T
Dtsch Med Wochenschr; 2019 Feb; 144(4):239-243. PubMed ID: 30759472
[TBL] [Abstract][Full Text] [Related]
35. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
[TBL] [Abstract][Full Text] [Related]
36. Vaccination in elite athletes.
Gärtner BC; Meyer T
Sports Med; 2014 Oct; 44(10):1361-76. PubMed ID: 24986118
[TBL] [Abstract][Full Text] [Related]
37. Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands.
Hoes J; Knol MJ; Mollema L; Buisman A; de Melker HE; van der Klis FRM
Vaccine; 2019 Jul; 37(32):4504-4510. PubMed ID: 31279563
[TBL] [Abstract][Full Text] [Related]
38. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
[TBL] [Abstract][Full Text] [Related]
39. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
40. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
